Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
July 27, 2026
Nextstrain virus-tracking platform moves into new phase
Dr. JT McCrone will oversee Gates Foundation-funded efforts to further empower users
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some
From the Joshua Hill Lab, Vaccine and Infectious Disease and Clinical Research Divisions
Mail-in immune monitoring brings clinical trials closer to home
From the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
PrEP-ping T cells for HIV exposure
From the Lund Lab, Vaccine and Infectious Disease Division
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Answering WHO’s call with a new way to track how well we’re fighting the flu
Fred Hutch researchers’ immunity data informs global vaccine updates
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Taming viral threats after lifesaving transplants
From the Boeckh Lab, Vaccine and Infectious Disease Division
Exposing viral vulnerabilities for targeted cancer vaccines
From the Boonyaratanakornkit, Phipps, Pancera, and McGuire Labs, Vaccine and Infectious Disease Division
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
CD16+ monocytes are the first responders to HIV reactivation
From the Cohn Lab, Vaccine and Infectious Disease Division